retatrutide Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide 10mg & 20mg Research

The US Anti-Doping Authority says there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions

Snap a photo and know in secondsno shame, no guessing

The burgeoning connection between GLP-1 use and eating disorders raises more questions about who might be a good fit for the medication and how clinicians can best support patients as they work through improvements or declines in their relationship with food

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the BrainAdipocyte Axis

According to the World Health Organization (WHO), a reported one billion people globally are currently living with obesity, while type 2 diabetes rates continue to climb across both high-income and developing economies